These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11836397)
21. Experimental myelitis in BALB/cN and C57BL/6N mice caused by herpes simplex virus type 1 compared with herpes simplex virus type 2. Nakazato I; Kinjo T; Sirirungsi W; Tsuhako K; Miyagi J; Higa M; Iwamasa T Pathol Res Pract; 2000; 196(9):635-45. PubMed ID: 10997739 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cis-acting downstream activation sequence is mediated by a cellular transcription factor. Guzowski JF; Singh J; Wagner EK J Virol; 1994 Dec; 68(12):7774-89. PubMed ID: 7966567 [TBL] [Abstract][Full Text] [Related]
23. The herpes simplex virus type 1 VP5 promoter contains a cis-acting element near the cap site which interacts with a cellular protein. Huang CJ; Petroski MD; Pande NT; Rice MK; Wagner EK J Virol; 1996 Mar; 70(3):1898-904. PubMed ID: 8627715 [TBL] [Abstract][Full Text] [Related]
24. The downstream activation sequence of the strict late Herpes Simplex Virus Type 1 U(L)38 promoter interacts with hTAF(II)70, a component of TFIID. Petroski MD; Devi-Rao GB; Rice MK; Wagner EK Virus Genes; 2001 Jun; 22(3):299-310. PubMed ID: 11450948 [TBL] [Abstract][Full Text] [Related]
25. Structural features of the scaffold interaction domain at the N terminus of the major capsid protein (VP5) of herpes simplex virus type 1. Huang E; Perkins EM; Desai P J Virol; 2007 Sep; 81(17):9396-407. PubMed ID: 17581992 [TBL] [Abstract][Full Text] [Related]
26. The transneuronal spread phenotype of herpes simplex virus type 1 infection of the mouse hind footpad. Engel JP; Madigan TC; Peterson GM J Virol; 1997 Mar; 71(3):2425-35. PubMed ID: 9032380 [TBL] [Abstract][Full Text] [Related]
27. Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein. Hong Z; Beaudet-Miller M; Durkin J; Zhang R; Kwong AD J Virol; 1996 Jan; 70(1):533-40. PubMed ID: 8523566 [TBL] [Abstract][Full Text] [Related]
28. Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors. Yamamoto S; Deckter LA; Kasai K; Chiocca EA; Saeki Y Gene Ther; 2006 Dec; 13(24):1731-6. PubMed ID: 16871231 [TBL] [Abstract][Full Text] [Related]
29. Mutations in the N-terminus of VP5 alter its interaction with the scaffold proteins of herpes simplex virus type 1. Warner SC; Chytrova G; Desai P; Person S Virology; 2001 Jun; 284(2):308-16. PubMed ID: 11384229 [TBL] [Abstract][Full Text] [Related]
30. Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. Bloom DC; Stevens JG J Virol; 1994 Jun; 68(6):3761-72. PubMed ID: 8189514 [TBL] [Abstract][Full Text] [Related]
31. Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach. Jin F; Li S; Zheng K; Zhuo C; Ma K; Chen M; Wang Q; Zhang P; Fan J; Ren Z; Wang Y PLoS One; 2014; 9(5):e96623. PubMed ID: 24794394 [TBL] [Abstract][Full Text] [Related]
32. Transactivation of the major capsid protein gene of herpes simplex virus type 1 requires a cellular transcription factor. Chen S; Mills L; Perry P; Riddle S; Wobig R; Lown R; Millette RL J Virol; 1992 Jul; 66(7):4304-14. PubMed ID: 1318406 [TBL] [Abstract][Full Text] [Related]
33. Analysis of factors influencing kinetics of herpes simplex virus transcription utilizing recombinant virus. Wagner EK; Petroski MD; Pande NT; Lieu PT; Rice M Methods; 1998 Sep; 16(1):105-16. PubMed ID: 9774520 [TBL] [Abstract][Full Text] [Related]
34. Herpes Simplex Virus 1 MicroRNA miR-H8 Is Dispensable for Latency and Reactivation Barrozo ER; Nakayama S; Singh P; Neumann DM; Bloom DC J Virol; 2021 Jan; 95(4):. PubMed ID: 33208453 [TBL] [Abstract][Full Text] [Related]
35. Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency. Berthomme H; Lokensgard J; Yang L; Margolis T; Feldman LT J Virol; 2000 Apr; 74(8):3613-22. PubMed ID: 10729137 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity. Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL J Virol; 2002 Sep; 76(18):9069-78. PubMed ID: 12186890 [TBL] [Abstract][Full Text] [Related]
37. The mutated tegument protein UL7 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of α-4 gene transcription. Xu X; Fan S; Zhou J; Zhang Y; Che Y; Cai H; Wang L; Guo L; Liu L; Li Q Virol J; 2016 Sep; 13(1):152. PubMed ID: 27618986 [TBL] [Abstract][Full Text] [Related]
38. Identification of the Capsid Binding Site in the Herpes Simplex Virus 1 Nuclear Egress Complex and Its Role in Viral Primary Envelopment and Replication. Takeshima K; Arii J; Maruzuru Y; Koyanagi N; Kato A; Kawaguchi Y J Virol; 2019 Nov; 93(21):. PubMed ID: 31391274 [TBL] [Abstract][Full Text] [Related]
40. Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice. Balliet JW; Kushnir AS; Schaffer PA Virology; 2007 May; 361(2):372-83. PubMed ID: 17207829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]